Medical Appliances & Equipment
(ZOLL) ZOLL Medical Corporation – Bull of the Day
We retain our Outperform recommendation on ZOLL Medical Corp. (ZOLL) following its forecast-topping first quarter results. Revenues and earnings for the quarter beat the Zacks Consensus Estimates, driven by strong sales from the company’s LifeVest and temperature management...
27Jan2012 | vitalstocks | 0 comments | Continued(ISRG) Intuitive Squarely Beats Earnings Expectations
Intuitive Surgical (ISRG) reported fourth quarter and fiscal 2011 earnings per share of $3.75 and $12.32, respectively, beating the Zacks Consensus Estimates of $3.34 and $11.89, respectively, while surpassing the corresponding year-ago results of $3.02 and $9.47. Revenues Intuitive...
25Jan2012 | vitalstocks | 0 comments | Continued(STJ) New Year Bets from MedTech
Picking the right stock is never easy, especially in a difficult and volatile market. There are thousands of stocks to choose from and many investors eventually end up boiling the ocean. The U.S. economy continues to be cramped by a spate of headwinds including a still unstable...
6Jan2012 | vitalstocks | 0 comments | Continued(STJ) Christmas Gift for the Ailing Heart
Wilson Greatbatch, the self-professed “humble tinkerer” and a trailblazer in medical technology, invented the first implantable cardiac pacemaker in 1958 which kept the rhythm of millions of heartbeats and preserved countless lives across the planet. A couple of decades...
14Dec2011 | vitalstocks | 0 comments | Continued(ZOLL) ZOLL Medical’s AutoPulse Tapped by WSPR Szczecin
Resuscitation devices maker ZOLL Medical (ZOLL) said that its new AutoPulse Plus cardiac support pumps has been bought by WSPR Szczecin, the biggest emergency service operator in Poland. The Polish entity has purchased 49 such devices to equip its fleet of ambulances. The innovative...
30Nov2011 | vitalstocks | 0 comments | Continued(HOLX) Hologic Launches C-View Software
Hologic (HOLX), a leading player in the field of women’s health, has released its C-View synthesized 2D image reconstruction algorithm. This eliminates the requirement of a conventional 2D mammogram as a part of a 3D mammography (tomosynthesis breast cancer screening). The...
30Nov2011 | vitalstocks | 0 comments | Continued(MDT) Medtronic 2012 Second Quarter Earnings Scorecard
The announcement of Medtronic’s (MDT) second quarter fiscal 2012 results, as on November 22, 2011, has led analysts to revise their estimates lower for the third quarter although the situation improves for the current fiscal. Second Quarter Highlights Medtronic reported an...
28Nov2011 | vitalstocks | 0 comments | Continued(ISRG) Intuitive Surgical 2011 Third Quarter Earnings Scorecard
Intuitive Surgical (ISRG) reported favorable third-quarter 2011 results. Earnings per share came in at $3.05, beating the Zacks Consensus Estimate of $2.76 and the year-ago figure of $2.14. Net income climbed 41.3% year over year to $122.4 million. Second Quarter Review Revenues...
22Nov2011 | vitalstocks | 0 comments | Continued(ZOLL) ZOLL Medical Corporation – Bull of the Day
We upgrade our recommendation on ZOLL Medical Corp. (ZOLL) to Outperform following its forecast-topping fourth quarter results. Revenues and earnings for the quarter outperformed the Zacks Consensus Estimates, driven by strong contributions from the company’s LifeVest and...
21Nov2011 | vitalstocks | 0 comments | Continued(MDT) Medical Technology Industry Stock Outlook – November 2011 – Industry Outlook
The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures,...
18Nov2011 | vitalstocks | 0 comments | Continued(EW) Edwards Lifesciences Earns FDA OK on Trial Enrollment
Recently, Edwards Lifesciences Corporation (EW) received conditional approval from the US Food and Drug Administration for enrollment of a certain group of patients in the PARTNER II trial. The trial is studying the company’s next-generation Sapien XT transcatheter heart valve...
10Nov2011 | vitalstocks | 0 comments | Continued(GB) Greatbatch Analyst Raises Shares to Outperform
We upgrade our recommendation on Greatbatch (GB) to Outperform following its impressive third-quarter 2011 results. Adjusted earnings of 41 cents for the quarter outstripped the Zacks Consensus Estimate of 34 cents. Profit surged 17% year over year. Sales rose 3% year over year...
6Nov2011 | vitalstocks | 0 comments | Continued(ALGN) Align Technology Beats The Street – Margins Lag
Align Technology (ALGN) reported third quarter 2011 adjusted EPS of 27 cents, beating the Zacks Consensus Estimate of 20 cents as well as the year-ago quarter adjusted EPS by 2 cents. Reported EPS was also ahead of the company’s guidance range of 17-20 cents. Total revenue...
4Nov2011 | vitalstocks | 0 comments | Continued(GB) Greatbatch Third Quarter 2011 Earnings Helped By Medical Business
Greatbatch’s (GB) third-quarter fiscal 2011 adjusted (excluding one-time items) earnings per share of 41 cents outpaced both the Zacks Consensus Estimate and the year-ago adjusted earnings of 34 cents. Profit (as reported) soared 17% year over year to roughly $7 million (or...
2Nov2011 | vitalstocks | 0 comments | Continued(EW) Edwards Lifesciences 2011 Fourth Quarter Earnings Scorecard
The announcement of Edwards Lifesciences’ (EW) third quarter fiscal 2011 results as on October 19, 2011, has led analysts to revise their estimates lower for the fourth quarter and fiscal 2011. Third Quarter Highlights Edwards reported an adjusted EPS of 38 cents in the third...
31Oct2011 | vitalstocks | 0 comments | Continued(SLTM) Solta Medical Reports LipoSonix Approval
Aesthetic laser treatments provider Solta Medical (SLTM) reported that Medicis Technologies Corporation, a unit of specialty pharmaceutical company Medicis Pharmaceutical Corporation (MRX), has won the U.S. approval for the second-generation LIPOSONIX system for non-invasive...
27Oct2011 | vitalstocks | 0 comments | Continued(EW) Edwards Lifesciences Corporation Earnings Preview
Edwards Lifesciences Corporation (EW) is scheduled to release its third quarter fiscal 2011 results on Wednesday, October 19, 2011 after the market closes. The company is expected to earn 39 cents per share during the quarter on $405 million in revenues, according to the Zacks...
18Oct2011 | vitalstocks | 0 comments | Continued(EW) Edwards Lifesciences Announces Share Buyback
Edwards Lifesciences Corporation (EW) recently announced a new share repurchase program worth $500 million. At the end of the second quarter of fiscal 2011, the company was left with $240 million of authorization. Edwards expects to repurchase approximately $100 million worth...
6Oct2011 | vitalstocks | 0 comments | Continued(EW) Edwards Lifesciences Sapien Under Centers for Medicare & Medicaid Services NCA
Edwards Lifesciences (EW) received a major setback as the Centers for Medicare & Medicaid Services (CMS) decided to initiate a National Coverage Analysis (NCA) of transcatheter aortic valve replacement (TAVR). As a result, the stock price of the company closed 6.58% lower...
2Oct2011 | vitalstocks | 0 comments | Continued(WMGI) Wright Medical Group Gets a New CEO
International orthopedic devices company Wright Medical Group (WMGI) recently reported that its Board of Directors chose Mr. Robert J. Palmisano as President and CEO, starting from September 17, 2011. Mr. David D. Stevens, who was interim President and CEO, will remain Chairman...
21Sep2011 | vitalstocks | 0 comments | Continued(SLTM) Solta Medical Buying Medicis Unit
Aesthetic laser treatments provider Solta Medical (SLTM) has agreed to acquire Medicis Technologies Corporation, a unit of specialty pharmaceutical company Medicis Pharmaceutical Corporation (MRX), in a deal worth roughly $35 million. Under the agreement, Soltawill pay $15 million...
20Sep2011 | vitalstocks | 0 comments | Continued(MDT) Medtronic Grows Spinal Portfolio
Leading medical devices player, Medtronic’s (MDT) TSRH Spinal System has received 510 (k) clearance from the US Food and Drug Administration (FDA) to treat adolescent idiopathic scoliosis (AIS) with pedicle screws. The system, developed in collaboration with Texas Scottish...
20Sep2011 | vitalstocks | 0 comments | Continued(WMGI) Wright Medical Group to Restructure
International orthopedic devices company Wright Medical Group (WMGI) recently reported that it is exercising a cost restructuring initiative to improve profitability, promote growth and strengthen cash flow, leading to enhanced shareholder value. The company believes that the...
20Sep2011 | vitalstocks | 0 comments | Continued(MDT) Medical Devices Stock Outlook – Sept. 2011 – Industry Outlook
June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected...
8Sep2011 | vitalstocks | 0 comments | Continued(CYBX) Cyberonics Stops Generator Shipment
Recently, the leading neuromodulation company Cyberonics (CYBX) stopped shipment of two models of its Aspire platform generators. The company is currently retrieving the already sold but unused models namely No. 105 and 106. The company has also suspended enrollment in its...
16Aug2011 | vitalstocks | 0 comments | Continued(GB) Greatbatch Analyst Reaffirms Shares at Neutral
We reiterate our Neutral recommendation for Greatbatch Inc. (GB). Second-quarter fiscal 2011 earnings per share of 43 cents met the Zacks Consensus Estimate. Revenues rose 4% year over year to $146.5 million, topping the Zacks Consensus Estimate of $141 million. Sales were boosted...
9Aug2011 | vitalstocks | 0 comments | Continued(KCI) Kinetic Concepts Aquired by Apax Partners and Two Canadian Pension Funds
Private equity firm Apax Partners and two Canadian pension funds are set to acquire leading medical technology company Kinetic Concepts (KCI). The deal, including Kinetic’s outstanding debt, is valued at approximately $6.3 billion. As an independent global partnership,...
14Jul2011 | vitalstocks | 0 comments | Continued(CYBX) Cyberonics Stays Neutral
We recently reiterated our Neutral recommendation on Cyberonics (CYBX) with a target price of $30.00, following our assessment of its fourth quarter 2011 results. Cyberonics reported fourth quarter 2011 EPS of 26 cents, which missed the Zacks Consensus Estimate of 29 cents and...
11Jul2011 | vitalstocks | 0 comments | Continued(ARAY) Accuray Presents Promising CyberKnife Radiosurgery Data
Leading radiosurgery systems maker Accuray Incorporated (ARAY) has presented encouraging new clinical data highlighting the benefits of its popular CyberKnife radiosurgery system and its recently acquired TomoTherapy radiation therapy system in treating a vast continuum of lung...
11Jul2011 | vitalstocks | 0 comments | Continued(RMD) ResMed Acquires BiancaMed
Developer and marketer of medical equipments for treating sleep disordered breathing and other respiratory disorders, ResMed Inc. (RMD) recently acquired an Irish medical technology company BiancaMed Ltd. As per the terms of the deal, ResMed purchased all outstanding shares of...
7Jul2011 | vitalstocks | 0 comments | Continued